A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)

Discontinued
Phase of Trial: Phase II

Latest Information Update: 04 Aug 2017

At a glance

  • Drugs Vatelizumab (Primary)
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Acronyms FUSCIA
  • Sponsors Sanofi
  • Most Recent Events

    • 20 May 2015 Status changed from active, no longer recruiting to discontinued as per ClinicalTrials.gov record.
    • 08 Oct 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Apr 2016 to 1 May 2016.
    • 26 Mar 2014 According to ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top